UBS Maintains Neutral on Clorox, Raises Price Target to $170
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Peter Grom maintains a Neutral rating on Clorox (NYSE:CLX) and raises the price target from $145 to $170.

February 02, 2024 | 6:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Peter Grom maintains a Neutral rating on Clorox and raises the price target from $145 to $170.
The increase in price target from $145 to $170 by UBS analyst Peter Grom, while maintaining a Neutral rating, suggests a positive outlook on Clorox's stock price in the short term. This adjustment reflects an expectation of improved performance or valuation metrics for Clorox, which could lead to increased investor interest and potentially a rise in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100